Holen Sie sich die Stockscreener-App
4.20
1.18%
-0.05
Schlusskurs vom Vortag:
$4.25
Offen:
$4.27
24-Stunden-Volumen:
60,747
Relative Volume:
0.34
Marktkapitalisierung:
$215.60M
Einnahmen:
$81.06M
Nettoeinkommen (Verlust:
$-55.55M
KGV:
-3.6842
EPS:
-1.14
Netto-Cashflow:
$-47.98M
1W Leistung:
+3.45%
1M Leistung:
+22.09%
6M Leistung:
+17.65%
1J Leistung:
-35.78%
1-Tages-Spanne:
$4.17
$4.29
1-Wochen-Bereich:
$4.018
$4.456
52-Wochen-Spanne:
$2.03
$8.45
Sight Sciences Inc Stock (SGHT) Company Profile
Firmenname
Sight Sciences Inc
Sektor
Branche
Telefon
(415) 889-0550
Adresse
4040 CAMPBELL AVE,, MENLO PARK
Vergleichen Sie SGHT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SGHT
Sight Sciences Inc
|
4.21 | 215.60M | 81.06M | -55.55M | -47.98M | -1.14 |
|
ABT
Abbott Laboratories
|
133.70 | 233.36B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
106.14 | 147.06B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
392.41 | 145.64B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
85.80 | 112.76B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.61 | 44.46B | 5.54B | 4.18B | 623.10M | 7.00 |
Sight Sciences Inc Stock (SGHT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-06 | Eingeleitet | UBS | Buy |
| 2024-11-04 | Herabstufung | Lake Street | Buy → Hold |
| 2024-08-21 | Eingeleitet | Lake Street | Buy |
| 2023-09-12 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-09-12 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-09-12 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2023-08-24 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-07-10 | Herabstufung | Citigroup | Buy → Neutral |
| 2023-01-06 | Hochstufung | Stifel | Hold → Buy |
| 2022-10-04 | Eingeleitet | Needham | Hold |
| 2022-07-26 | Eingeleitet | Stifel | Hold |
| 2022-02-03 | Eingeleitet | William Blair | Outperform |
| 2022-01-07 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
Alle ansehen
Sight Sciences Inc Aktie (SGHT) Neueste Nachrichten
Sight Sciences (SGHT) Price Target Raised by Piper Sandler | SGHT Stock News - GuruFocus
Piper Sandler raises Sight Sciences price target to $4 on technology outlook - Investing.com India
Sight Sciences (SGHT) Sees Price Target Increase Amid Market Recovery | SGHT Stock News - GuruFocus
Sight Sciences price target raised to $4 from $3.50 at Piper Sandler - TipRanks
Sight Sciences Uses RWE To Refine Patient Segmentation And Reverse A Medicare Ruling For OMNI - Clinical Leader
Millennium Management LLC Invests $464,000 in Sight Sciences, Inc. (NASDAQ:SGHT) - Defense World
Sight Sciences director Encrantz buys $381,957 in common stock By Investing.com - Investing.com Nigeria
Sight Sciences director Encrantz buys $381,957 in common stock - Investing.com Australia
sight sciences appoints new board member and holds annual meeting By Investing.com - Investing.com South Africa
sight sciences appoints new board member and holds annual meeting - Investing.com India
Sight Sciences Holds Annual Stockholders Meeting - TipRanks
ProShare Advisors LLC Makes New $36,000 Investment in Sight Sciences, Inc. (NASDAQ:SGHT) - Defense World
Sight sciences director Encrantz buys $376,429 in stock By Investing.com - Investing.com Nigeria
Sight sciences director Encrantz buys $376,429 in stock - Investing.com Australia
Sight Sciences Independent Chairman Acquires 7.8% More Stock - simplywall.st
Sight Sciences, Inc. (NASDAQ:SGHT) Receives Consensus Rating of “Hold” from Analysts - Defense World
Sight sciences director Staffan Encrantz buys $451k in stock By Investing.com - Investing.com UK
Sight sciences director Staffan Encrantz buys $451k in stock - Investing.com Australia
BNP Paribas Financial Markets Invests $262,000 in Sight Sciences, Inc. (NASDAQ:SGHT) - Defense World
Sight Sciences, Inc. (NASDAQ:SGHT) Shares Sold by Bank of America Corp DE - Defense World
Northern Trust Corp Has $1.21 Million Stock Holdings in Sight Sciences, Inc. (NASDAQ:SGHT) - Defense World
Sight Sciences at Stifel Forum: Strategic Growth Amid Challenges By Investing.com - Investing.com Canada
Sight Sciences price target raised to $3.60 from $3.20 at Citi - TipRanks
D. E. Shaw & Co. Inc. Acquires 88,738 Shares of Sight Sciences, Inc. (NASDAQ:SGHT) - Defense World
Sight Sciences (SGHT) Receives Increased Price Target from Citigroup | SGHT Stock News - GuruFocus
Sight Sciences (SGHT) Receives Increased Price Target from Citig - GuruFocus
Sight Sciences (SGHT) Target Price Raised by Citi | SGHT Stock News - GuruFocus
Sight Sciences, Inc. (NASDAQ:SGHT) Shares Purchased by Dimensional Fund Advisors LP - Defense World
Nautilus Biotechnology And 2 Other Penny Stocks With Promising Potential - simplywall.st
Sight Sciences to Present at the Stifel 2025 Virtual Ophthalmology Forum on May 27th - The Manila Times
Sight Sciences Reveals New Ophthalmology Tech Updates at Exclusive Stifel 2025 ForumLive Webcast Available - Stock Titan
Sight Sciences, Inc. (NASDAQ:SGHT) Surges 44% Yet Its Low P/S Is No Reason For Excitement - simplywall.st
Sight Sciences, Inc. (NASDAQ:SGHT) Shares Acquired by Wells Fargo & Company MN - Defense World
Sight Sciences, Inc. (NASDAQ:SGHT) Shares Purchased by Barclays PLC - Defense World
Sight Sciences (NASDAQ:SGHT) Price Target Raised to $3.00 - Defense World
Sight Sciences, Inc. (NASDAQ:SGHT) Q1 2025 Earnings Call Transcript - MSN
Analysts Have Conflicting Sentiments on These Healthcare Companies: Evolent Health (EVH), Verastem (VSTM) and Sight Sciences (SGHT) - The Globe and Mail
Sight Sciences (SGHT) Price Target Raised Amid Growth Potential - GuruFocus
Sight Sciences (SGHT) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates - MSN
Sight Sciences, Inc. Earnings Call: Mixed Results and Strategic Focus - TipRanks
Earnings call transcript: Sight Sciences misses Q1 2025 EPS forecast, stock rises - Investing.com Nigeria
Sight Sciences stock holds as Needham reiterates rating By Investing.com - Investing.com Nigeria
Sight Sciences stock holds as Needham reiterates rating - Investing.com
Sight Sciences: Balancing Resilience and Caution Amid Tariff Challenges - TipRanks
Sight Sciences (SGHT): Analyst Raises Price Target Despite Hold Rating | SGHT Stock News - GuruFocus
Sight Sciences Inc (SGHT) Q1 2025 Earnings Call Highlights: Navigating Market Challenges and ... By GuruFocus - Investing.com Canada
Finanzdaten der Sight Sciences Inc-Aktie (SGHT)
Umsatz
Nettogewinn
Free Cashflow
ENV
Sight Sciences Inc-Aktie (SGHT) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Encrantz Staffan | Director |
Jun 06 '25 |
Buy |
4.22 |
27,900 |
117,738 |
1,377,964 |
| Encrantz Staffan | Director |
Jun 04 '25 |
Buy |
4.17 |
21,674 |
90,424 |
1,278,161 |
| Encrantz Staffan | Director |
May 30 '25 |
Buy |
3.67 |
42,753 |
156,904 |
1,200,458 |
| Encrantz Staffan | Director |
Jun 02 '25 |
Buy |
3.88 |
30,799 |
119,439 |
1,231,257 |
| Encrantz Staffan | Director |
Jun 03 '25 |
Buy |
3.97 |
25,230 |
100,087 |
1,256,487 |
| Encrantz Staffan | Director |
May 29 '25 |
Buy |
3.59 |
60,128 |
215,739 |
1,157,705 |
| Encrantz Staffan | Director |
May 27 '25 |
Buy |
3.44 |
41,346 |
142,065 |
1,070,862 |
| Encrantz Staffan | Director |
May 28 '25 |
Buy |
3.52 |
26,715 |
93,930 |
1,097,577 |
| Bauerlein Alison | Chief Financial Officer |
May 19 '25 |
Sale |
3.48 |
13,066 |
45,430 |
636,728 |
0.23%
0.20%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):